Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s marketed products include Glatopa and Enoxaparin Sodium Injection. Its pipeline portfolio includes biosimilar as well its own novel product candidates. The company utilizes its technology such as Sialylation platform and SIFbody platform for developing generic versions, biosimilars, complex drugs, and potentially interchangeable biologics, and also in the discovery and development of therapeutics for various cancers and autoimmune indications. The company markets its products through its collaborative partners. Momenta is headquartered in Cambridge, Massachusetts, the US.
Explore premium data & analytics
Products and Services
Products |
---|
Marketed: |
Glatiramer Acetate Injection |
Enoxaparin Sodium Injection |
XXX |
XXX |
XXX |
Competitor Comparison
Key Parameters | Momenta Pharmaceuticals Inc | Sanofi | Amgen Inc | Teva Pharmaceutical Industries Ltd | Biogen Inc |
---|---|---|---|---|---|
Headquarters | United States of America | France | United States of America | Israel | United States of America |
City | Cambridge | Paris | Thousand Oaks | Tel Aviv | Cambridge |
State/Province | Massachusetts | - | California | Tel Aviv | Massachusetts |
No. of Employees | - | 95,442 | 24,200 | 37,037 | 9,610 |
Entity Type | Private | Public | Public | Public | Public |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Bruce Downey | Chairman | Executive Board | 2018 | 72 |
Craig A Wheeler | Chief Executive Officer; Director; President | Executive Board | 2006 | 59 |
Young Kwon, Ph.D. | Chief Business Officer; Chief Financial Officer | Senior Management | 2020 | 48 |
Agnieszka Cieplinska | Chief Accounting Officer | Senior Management | 2020 | - |
Alejandra Carvajal | Chief Legal Officer; General Counsel; Secretary | Senior Management | 2018 | 47 |
Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer